Elaine O'Hara
EVP, Chief Strategy Officer, Novavax.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 3, 2026Shares withheld for tax 22,429 shares at $9.49 of Novavax2
- Mar 3, 2026Exercised options 56,334 shares of Novavax2
- Mar 1, 2026Shares withheld for tax 10,969 shares at $10.14 of Novavax3
- Mar 1, 2026Exercised options 40,000 shares of Novavax3
- Mar 1, 2026Shares withheld for tax 5,375 shares at $10.14 of Novavax3
- Mar 1, 2026Exercised options 19,600 shares of Novavax3
- Mar 1, 2025Shares withheld for tax 10,969 shares at $8.33 of Novavax4
- Mar 1, 2025Shares withheld for tax 5,375 shares at $8.33 of Novavax4
- Mar 1, 2025Exercised options 40,000 shares of Novavax4
- Mar 1, 2025Exercised options 19,600 shares of Novavax4
- Mar 1, 2024Shares withheld for tax 5,375 shares at $5.39 of Novavax5
- Mar 1, 2024Exercised options 19,600 shares at $5.39 of Novavax5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNovavax, EVP, Chief Strategy Officer
- 2
- 3SEC EDGARForm 4 filed Mar 3, 2026
- 4SEC EDGARForm 4 filed Mar 4, 2025
- 5SEC EDGARForm 4 filed Mar 5, 2024